| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/04/2002 | WO2002026984A2 Potassium channel interactors and uses therefor |
| 04/04/2002 | WO2002026950A2 Transferases |
| 04/04/2002 | WO2002026833A1 Compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/04/2002 | WO2002026830A1 Method for producing human anti-thymocyte immunoglobulins |
| 04/04/2002 | WO2002026822A2 Pumpcn compositions and uses thereof |
| 04/04/2002 | WO2002026801A2 Secreted proteins and their uses |
| 04/04/2002 | WO2002026785A2 Epitopes of virus hepatitis c specifically cd4+ t lymphocytes |
| 04/04/2002 | WO2002026784A2 Matrix proteins m1 and m2 of infections salmon anaemia virus |
| 04/04/2002 | WO2002026778A2 Isolated peptides which bind to hla-c molecules and uses thereof |
| 04/04/2002 | WO2002026757A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 04/04/2002 | WO2002026258A2 Treatment of immune-mediated diseases by oral administration of plasma fractions |
| 04/04/2002 | WO2002026257A1 Antibodies to the propeptide of candida albicans and methods of use |
| 04/04/2002 | WO2002026256A1 Excessive antibody production inhibitors, process for producing the same and method of using the same |
| 04/04/2002 | WO2002026255A1 New immunogenic complex |
| 04/04/2002 | WO2002026252A1 A vaccine for influenza virus and its preparation |
| 04/04/2002 | WO2002026250A2 Vaccines for proliferative ileitis |
| 04/04/2002 | WO2002026240A2 Inhibition of antigen presentation with poorly catabolized polymers |
| 04/04/2002 | WO2002026212A2 Microparticle compositions and methods for the manufacture thereof |
| 04/04/2002 | WO2002026209A2 Microparticles for delivery of the heterologous nucleic acids |
| 04/04/2002 | WO2002026193A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 04/04/2002 | WO2002008435A8 Codon-optimized papilloma virus sequences |
| 04/04/2002 | WO2002004636A8 NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS |
| 04/04/2002 | WO2002003961B1 Microspheres and adjuvants for dna vaccine delivery |
| 04/04/2002 | WO2002000662B1 Improvements in and relating to chromophores |
| 04/04/2002 | WO2002000251A9 Vaccine against foot-and-mouth disease |
| 04/04/2002 | WO2001097837A8 Solubilised protein vaccines |
| 04/04/2002 | WO2001096587A8 Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus |
| 04/04/2002 | WO2001093893A3 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 04/04/2002 | WO2001085980A3 Enzymatic assays for screening anti-cancer agents |
| 04/04/2002 | WO2001085784A3 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF |
| 04/04/2002 | WO2001083699A3 Ehrlichia chaffeensis 28 kda outer membrane protein multigene family |
| 04/04/2002 | WO2001081584A3 27960, a novel ubiquitin conjugating enzyme family member and uses therefor |
| 04/04/2002 | WO2001080882A3 Methods and compositions for eliciting an immune response |
| 04/04/2002 | WO2001078775A3 A method for making an hiv vaccine |
| 04/04/2002 | WO2001076622A3 Immunogenic peptides derived from prostate-specific antigen (psa) and uses thereof |
| 04/04/2002 | WO2001072846A3 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 04/04/2002 | WO2001072839A3 Human g-protein coupled receptors |
| 04/04/2002 | WO2001066741A3 Kcnb: a novel potassium channel protein |
| 04/04/2002 | WO2001062778A3 Tumour-specific animal proteins |
| 04/04/2002 | WO2001055178A9 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 04/04/2002 | WO2001053353A3 Recombinant antibodies to human interkleukin-1 beta |
| 04/04/2002 | WO2001053352A3 Sperm specific proteins |
| 04/04/2002 | WO2001049715A3 Methods and compositions for inhibiting neoplastic cell growth |
| 04/04/2002 | WO2001034802A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 04/04/2002 | WO2001030390A3 Method |
| 04/04/2002 | WO2001025254A3 Novel adjuvant comprising a lipopolysaccharide antagonist |
| 04/04/2002 | WO2000072021A3 Cancer associated antigens and uses therefor |
| 04/04/2002 | WO2000057909A9 Attenuated dengue-2 virus vaccine |
| 04/04/2002 | US20020040203 Method for transdermal or intradermal delivery of molecules |
| 04/04/2002 | US20020040009 Novel ratA |
| 04/04/2002 | US20020040005 Comprising tannic acid or tannin complexes from the sap of a plant of the Musaceas Family and a pharmaceutically acceptable carrier |
| 04/04/2002 | US20020039764 Nucleic, acids, proteins, and antibodies |
| 04/04/2002 | US20020039756 Evaluation and classification of toxicity in humans; obtain samples, incubate with antibodies, detect bound complexes, increased concentration of bound complexes indicates toxicity in humans |
| 04/04/2002 | US20020039755 Conjugate vaccine against gram-negative bacterial infections |
| 04/04/2002 | US20020039589 Veterinary medicine; against Pasteurella caused disease |
| 04/04/2002 | US20020039588 Compounds and methods for the treatment and prevention of bacterial infection |
| 04/04/2002 | US20020039586 Lyme disease |
| 04/04/2002 | US20020039585 Mutants of streptococcal toxin c and methods of use |
| 04/04/2002 | US20020039584 Vaccine |
| 04/04/2002 | US20020039583 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/04/2002 | US20020039582 Using antigen; oil in water emulsion |
| 04/04/2002 | US20020039581 Antibodies against CTLA4 and uses therefor |
| 04/04/2002 | US20020039579 Immunoglobulin antibodies |
| 04/04/2002 | US20020039578 Methods for treating disease with antibodies to CXCR3 |
| 04/04/2002 | US20020039577 Methods for regulating a lymphocyte-mediated immune response by blocking costimulatory signals and blocking LFA-1 mediated adhesion in lymphocytes |
| 04/04/2002 | US20020039573 Administering antigen; genetic engineering |
| 04/04/2002 | US20020039571 Injectable vaccine |
| 04/04/2002 | US20020039569 Activation; separation |
| 04/04/2002 | US20020039557 Anticarcinogenic agents; immunosuppressant |
| 04/04/2002 | DE10045591A1 Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine) Site-specific, antibody-mediated activation of proapoptotic cytokines - Amaize (Antibody Mediated Apoptosis Inducing cytokines) |
| 04/04/2002 | CA2423991A1 Pumpcn compositions and uses thereof |
| 04/04/2002 | CA2423805A1 Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin g |
| 04/04/2002 | CA2423797A1 Antibodies to the propeptide of candida albicans and methods of use |
| 04/04/2002 | CA2423708A1 Method for producing human anti-thymocyte immunoglobulins |
| 04/04/2002 | CA2423694A1 Transferases |
| 04/04/2002 | CA2423588A1 Improved vaccines for proliferative ileitis and methods of making and using the same |
| 04/04/2002 | CA2423487A1 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 04/04/2002 | CA2423413A1 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 04/04/2002 | CA2420960A1 Potassium channel interactors and uses therefor |
| 04/04/2002 | CA2416656A1 Compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/03/2002 | EP1192280A1 Synthetic ligation reassembly in directed evolution |
| 04/03/2002 | EP1192268A2 Nucleic acid binding of multi-zinc finger transcription factors |
| 04/03/2002 | EP1192250A2 Human rna metabolism proteins (rmep) |
| 04/03/2002 | EP1192249A1 47 human secreted proteins |
| 04/03/2002 | EP1192247A1 Sphingosine kinase enzyme |
| 04/03/2002 | EP1192242A1 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 04/03/2002 | EP1192185A2 Apo-2L RECEPTOR AGONIST AND CPT-11 SYNERGISM |
| 04/03/2002 | EP1192179A2 Compound derived from an offset orf of the ice gene |
| 04/03/2002 | EP1192174A2 Antagonists of bmp and tgf beta signalling pathways |
| 04/03/2002 | EP1192147A1 Mycolactone and related compounds, compositions and methods of use |
| 04/03/2002 | EP1191975A2 Improvement of t cell mediated immunity |
| 04/03/2002 | EP1191945A1 Methods and compositions for control of bone formation via modulation of leptin activity |
| 04/03/2002 | EP1191944A2 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES |
| 04/03/2002 | EP1191943A1 Novel anti-allergic agents |
| 04/03/2002 | EP1191940A1 Tumor necrosis factor receptor 5 |
| 04/03/2002 | EP1042001B1 Use of microparticles combined with submicron oil-in-water emulsions |
| 04/03/2002 | EP0939649B1 Additive, in particular in the form of an emulsion containing a trivalent metal cation and vaccine composition containing same |
| 04/03/2002 | EP0859957B1 Patient-specific immunoadsorbents for extracorporal apheresis and methods of producing said immuno-adsorbers |
| 04/03/2002 | EP0856051B1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
| 04/03/2002 | EP0850069B1 Method for inducing humoral and cellular immune responses utilizing intracellular delivery of peptide-coated microparticles |